Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Citadel Advisors LLC | 2,136,115 5.600% | 15,782 (+0.74%) | Filing History |
| 2021-02-16 4:30 pm Unchanged | 2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Citadel Advisors LLC | 22,690 7.300% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Citadel Advisors LLC | 25,487 0.200% | -512,178 (-95.26%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | CAPITOL INVT CORP V COM CAP | Citadel Advisors LLC | 1,869,059 5.400% | 1,869,059 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Simplify China A Shares PLUS Income ETF CAS | Citadel Advisors LLC | 1,250,082 5.400% | 1,250,082 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Citadel Advisors LLC | 6,660,717 3.800% | -2,234,718 (-25.12%) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | Citadel Advisors LLC | 2,194,035 2.100% | -1,198,589 (-35.33%) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | AVROBIO, Inc. AVRO | Citadel Advisors LLC | 139,068 4.000% | -1,684 (-1.20%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | SuRo Capital Corp. SSSS | Citadel Advisors LLC | 1,276,990 6.100% | 169,174 (+15.27%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | CONCORD ACQUISI CORP CNDU | Citadel Advisors LLC | 1,800,094 6.300% | 16 (+0.00%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | L&F Acquisition Corp. LNFA | Citadel Advisors LLC | 870,009 5.000% | 3,072 (+0.35%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Bull Horn Holdings Corp. BHSE | Citadel Advisors LLC | 623,209 6.500% | 623,209 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Citadel Advisors LLC | 1,301,804 2.900% | -427,172 (-24.71%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Spring Valley Acquisition Corp. SV | Citadel Advisors LLC | 1,346,600 5.900% | 1,346,600 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Citadel Advisors LLC | 1,503,870 3.700% | -626,094 (-29.39%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | EdtechX Holdings Acquisition Corp. II EDTXU | Citadel Advisors LLC | 550,558 4.800% | 460 (+0.08%) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Periphas Capital Partnering Corporation PCPC | Citadel Advisors LLC | 800,752 4.800% | 800,752 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Vincerx Pharma, Inc. VINC | Citadel Advisors LLC | 31,897 4.500% | 31,897 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | PropTech Investment Corporation II PTIC | Citadel Advisors LLC | 1,172,713 5.100% | 1,172,713 (New Position) | Filing History |
| 2021-02-16 4:30 pm Purchase | 2020-12-31 | 13G | Mudrick Capital Acquisition Corporation II MUDS | Citadel Advisors LLC | 1,480,068 4.700% | 1,480,068 (New Position) | Filing History |